Michael Clapcich Fund For is categorized under Physicians Offices in Stirling, NJ and active since 2008.
Michael Clapcich Fund For was established in 2008, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6219992 by the NAICS.
If you are seeking more information, feel free to contact Robert Clapcich at the company’s single location by writing to 678 Chestnut St, Stirling, New Jersey NJ 07980 or by phoning (908) 604-8518. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Michael Clapcich Fund For |
| Contact Person: | Robert Clapcich |
| Address: | 678 Chestnut St, Stirling, New Jersey 07980 |
| Phone Number: | (908) 604-8518 |
| Website Address: | michaelsfund.org |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 6219992 |
| Share This Business: |
Michael Clapcich Fund For was started in 2008 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6219992. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Robert Clapcich for inquiries that concern Michael Clapcich Fund For by calling the company number (908) 604-8518, as your correspondence is most welcome. Additionally, the physical location of the single location of Michael Clapcich Fund For can be found at the coordinates 40.673451,-74.510326 as well as the street address 678 Chestnut St in Stirling, New Jersey 07980.
For its online presence, you may visit Michael Clapcich Fund For’s website at michaelsfund.org and engage with its social media outlets through on Twitter and on Facebook.